Literature DB >> 7873926

Complement-dependent cytotoxic activity of serum mannan-binding protein towards mammalian cells with surface-exposed high-mannose type glycans.

M Ohta1, T Kawasaki.   

Abstract

Serum mannan-binding protein (S-MBP), a lectin specific for mannose and N-acetylglucosamine, activates complement through the classical pathway. With the help of complement, S-MBP lyses red blood cells which have been coated with yeast mannan and kills bacteria which have N-acetylglucosamine and/or L-glycero-D-manno-heptose on their core oligosaccharide. In this study, we examined whether mammalian cells, on which S-MBP could bound, are killed by a complement-dependent mechanism. When baby hamster kidney (BHK) cells were treated with an alpha-mannosidase inhibitor, 1-deoxymannojirimycin (dMM), most of the cellular oligosaccharides were transformed from the complex-type to the high mannose-type. S-MBP bound to the dMM-treated BHK cells in the presence of Ca2+, and this binding was eliminated by mannose. When dMM-treated cells, labelled with 51Cr, were incubated with complement, radioactivity was released in a dose-dependent manner by S-MBP and complement. This release was not observed with heat-inactivated complement. These observations suggest that S-MBP is able, with the help of complement, to kill not only exogenous microorganisms but also mammalian cells which have high mannose-type oligosaccharides exposed on their surfaces.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7873926     DOI: 10.1007/bf00731203

Source DB:  PubMed          Journal:  Glycoconj J        ISSN: 0282-0080            Impact factor:   2.916


  25 in total

1.  Neoglycolipids as probes of oligosaccharide recognition by recombinant and natural mannose-binding proteins of the rat and man.

Authors:  R A Childs; K Drickamer; T Kawasaki; S Thiel; T Mizuochi; T Feizi
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

2.  Asparagine-linked oligosaccharides of BHK cells treated with inhibitors of oligosaccharide processing.

Authors:  R C Hughes; L Foddy; E Bause
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

3.  Glycosylation inhibitors for N-linked glycoproteins.

Authors:  A D Elbein
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

4.  Mannose-binding proteins isolated from rat liver contain carbohydrate-recognition domains linked to collagenous tails. Complete primary structures and homology with pulmonary surfactant apoprotein.

Authors:  K Drickamer; M S Dordal; L Reynolds
Journal:  J Biol Chem       Date:  1986-05-25       Impact factor: 5.157

5.  Role of the collagen-like domain of the human serum mannan-binding protein in the activation of complement and the secretion of this lectin.

Authors:  H Kurata; H M Cheng; Y Kozutsumi; Y Yokota; T Kawasaki
Journal:  Biochem Biophys Res Commun       Date:  1993-03-31       Impact factor: 3.575

6.  Identical point mutation leading to low levels of mannose binding protein and poor C3b mediated opsonisation in Chinese and Caucasian populations.

Authors:  R J Lipscombe; Y L Lau; R J Levinsky; M Sumiya; J A Summerfield; M W Turner
Journal:  Immunol Lett       Date:  1992-05       Impact factor: 3.685

7.  A human serum mannose-binding protein inhibits in vitro infection by the human immunodeficiency virus.

Authors:  R A Ezekowitz; M Kuhlman; J E Groopman; R A Byrn
Journal:  J Exp Med       Date:  1989-01-01       Impact factor: 14.307

8.  The human mannose-binding protein functions as an opsonin.

Authors:  M Kuhlman; K Joiner; R A Ezekowitz
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

9.  Human leukocyte C1q receptor binds other soluble proteins with collagen domains.

Authors:  R Malhotra; S Thiel; K B Reid; R B Sim
Journal:  J Exp Med       Date:  1990-09-01       Impact factor: 14.307

10.  Activation of the classical complement pathway by mannose-binding protein in association with a novel C1s-like serine protease.

Authors:  M Matsushita; T Fujita
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

View more
  5 in total

1.  Antitumor activity of mannan-binding protein in vivo as revealed by a virus expression system: mannan-binding proteindependent cell-mediated cytotoxicity.

Authors:  Y Ma; K Uemura; S Oka; Y Kozutsumi; N Kawasaki; T Kawasaki
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

2.  Human serum mannose-binding lectin (MBL)-associated serine protease-1 (MASP-1): determination of levels in body fluids and identification of two forms in serum.

Authors:  I Terai; K Kobayashi; M Matsushita; T Fujita
Journal:  Clin Exp Immunol       Date:  1997-11       Impact factor: 4.330

3.  Superoxide production from human polymorphonuclear leukocytes by human mannan-binding protein (MBP).

Authors:  Kazuhide Uemura; Harumi Yamamoto; Tomoaki Nakagawa; Kishiko Nakamura; Nobuko Kawasaki; Shogo Oka; Bruce Yong Ma; Toshisuke Kawasaki
Journal:  Glycoconj J       Date:  2004       Impact factor: 2.916

Review 4.  An overview on human serum lectins.

Authors:  S Beulaja Manikandan; R Manikandan; M Arumugam; P Mullainadhan
Journal:  Heliyon       Date:  2020-08-27

5.  Plasma Proteome Signature to Predict the Outcome of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy.

Authors:  Sungchan Gwark; Hee-Sung Ahn; Jeonghun Yeom; Jiyoung Yu; Yumi Oh; Jae Ho Jeong; Jin-Hee Ahn; Kyung Hae Jung; Sung-Bae Kim; Hee Jin Lee; Gyungyub Gong; Sae Byul Lee; Il Yong Chung; Hee Jeong Kim; Beom Seok Ko; Jong Won Lee; Byung Ho Son; Sei Hyun Ahn; Kyunggon Kim; Jisun Kim
Journal:  Cancers (Basel)       Date:  2021-12-14       Impact factor: 6.639

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.